{"id":7623,"date":"2022-06-14T12:08:58","date_gmt":"2022-06-14T09:08:58","guid":{"rendered":"https:\/\/www.norameda.com\/anton-gonak-onkologijas-un-slimnicu-biznesa-nodalas-vaditajs-mes-stradajam-musu-klientu-laba-un-kopa-ar-tiem\/"},"modified":"2022-06-14T12:10:38","modified_gmt":"2022-06-14T09:10:38","slug":"anton-gonak-onkologijas-un-slimnicu-biznesa-nodalas-vaditajs-mes-stradajam-musu-klientu-laba-un-kopa-ar-tiem","status":"publish","type":"post","link":"https:\/\/www.norameda.com\/lv\/anton-gonak-onkologijas-un-slimnicu-biznesa-nodalas-vaditajs-mes-stradajam-musu-klientu-laba-un-kopa-ar-tiem\/","title":{"rendered":"Anton Gonak, onkolo\u0123ijas un slimn\u012bcu biznesa noda\u013cas vad\u012bt\u0101js: “M\u0113s str\u0101d\u0101jam m\u016bsu klientu lab\u0101 un kop\u0101 ar tiem”"},"content":{"rendered":"

Anton Gonak uz\u0146\u0113mum\u0101 \u201cNorameda\u201d s\u0101ka str\u0101d\u0101t pirms 14 gadiem. Jaunais speci\u0101lists toreiz to d\u0113v\u0113ja par “viena aktiera te\u0101tri”. \u0160obr\u012bd tie ir vair\u0101ki komp\u0101nijas \u201cNorameda\u201d cilv\u0113ki, kuri str\u0101d\u0101 onkolo\u0123ijas, hematolo\u0123ijas un transplantolo\u0123ijas nozar\u0113, un A.Gonak vada \u0161o noda\u013cu.<\/p>\n

“Jaunu produktu ievie\u0161ana tirg\u016b, p\u0101rdo\u0161ana un m\u0101rketings ir m\u016bsu ikdiena, ar\u012b darbs pie da\u017e\u0101diem projektiem,” st\u0101sta A. Gonak. “M\u016bsu m\u0113r\u0137is ir nodro\u0161in\u0101t lab\u0101kos risin\u0101jumus, kas nepiecie\u0161ami m\u016bsu vesel\u012bbas apr\u016bpes speci\u0101listiem un pacientiem.”<\/p>\n

Mekl\u0113jot risin\u0101jumus<\/strong><\/h3>\n

Run\u0101jot par noda\u013cu, ko vi\u0146\u0161 izveidoja no nulles, A. Gonak uzsver klientu vajadz\u012bbu noz\u012bmi – pacientiem ir j\u0101sa\u0146em vi\u0146iem nepiecie\u0161am\u0101s z\u0101les. Un bez jebk\u0101diem kompromisiem.<\/p>\n

“COVID pand\u0113mijas laik\u0101 bija da\u017ei izaicin\u0101jumi – da\u017eos gad\u012bjumos v\u0113\u017ea slimniekiem bija gr\u016bti sa\u0146emt \u0101rst\u0113\u0161anu, jo vi\u0146i nevar\u0113ja br\u012bvi p\u0101rvietoties infekcijas riska d\u0113\u013c,” st\u0101sta A. Gonak. T\u0101d\u0113\u013c tika mekl\u0113ti risin\u0101jumi.<\/p>\n

Ar\u012b zin\u0101\u0161anas par jaun\u0101kajiem atkl\u0101jumiem ir b\u016btiskas, lai pacienti sa\u0146emtu modernu un atbilsto\u0161u \u0101rst\u0113\u0161anu. \u201cSadarb\u012bb\u0101, inform\u0101cijas apmai\u0146\u0101 zino\u0161\u0101ki k\u013c\u016bstam m\u0113s visi: gan komp\u0101nijas cilv\u0113ki, gan medi\u0137i. Zinot par jaun\u0101kajiem v\u0113\u017ea \u0101rst\u0113\u0161anas veidiem vai vismodern\u0101kaj\u0101m oper\u0113\u0161anas metod\u0113m pacientiem, kuriem tiek veikta transplant\u0101cija, pacientam tiek nodro\u0161in\u0101ta vispiem\u0113rot\u0101k\u0101 un lab\u0101k\u0101 terapija,\u201d p\u0101rliecin\u0101ts ir A. Gonak.<\/p>\n

Galven\u0101 v\u0113rt\u012bba \u2013 pacienta dz\u012bv\u012bba<\/strong><\/h3>\n

\u201cTie\u0161\u0101 p\u0101rdo\u0161ana nav m\u016bsu galvenais m\u0113r\u0137is. M\u0113s cen\u0161amies b\u016bt p\u0113c iesp\u0113jas zino\u0161\u0101ki, lai m\u016bsu pacienti sa\u0146emtu atbilsto\u0161u, inovat\u012bvu, pasaules l\u012bme\u0146a \u0101rst\u0113\u0161anu un efekt\u012bvas un pieejamas z\u0101les,\u201d saka A. Gonak.<\/p>\n

Pilotprojekti, kuros iesaist\u012bti pacienti un \u0101rsti, parasti s\u0101kas Lietuv\u0101. P\u0113c tam, p\u0101rbaudot projektu efektivit\u0101ti, tie tiek realiz\u0113ti ar\u012b cit\u0101s \u201cNorameda\u201d strukt\u016brvien\u012bb\u0101s da\u017e\u0101d\u0101s valst\u012bs.<\/p>\n

Z\u0101\u013cu iek\u013cau\u0161anu kompens\u0113jamo medikamentu sarakst\u0101 A. Gonak uzskata par noz\u012bm\u012bgu savas noda\u013cas darba da\u013cu. Lai to veicin\u0101tu, noz\u012bm\u012bga ir instit\u016bciju, medi\u0137u un sabiedr\u012bbas inform\u0113\u0161ana. L\u012bdz ar to prezent\u0101cijas da\u017e\u0101d\u0101m pacientu asoci\u0101cij\u0101m, universit\u0101t\u0113m, kl\u012bnik\u0101m un speci\u0101listiem ir ikdienas sast\u0101vda\u013ca.<\/p>\n

\u201cM\u0113s str\u0101d\u0101jam cie\u0161\u0101 sadarb\u012bb\u0101 ar \u0101rstiem un pacientiem, k\u0101 ar\u012b analiz\u0113jam tendences Eiropas tirg\u016b,\u201d skaidro \u201cNorameda\u201d onkolo\u0123ijas un slimn\u012bcu biznesa noda\u013cas vad\u012bt\u0101js. \u201cUn, lai ar\u012b Lietuv\u0101 situ\u0101cija uzlabojas, kompens\u0113jamo medikamentu saraksts joproj\u0101m nav tik pla\u0161s k\u0101 cit\u0101s ES valst\u012bs. L\u012bdz\u012bgas probl\u0113mas rodas ar\u012b ar da\u017e\u0101du \u0101rst\u0113\u0161anas sh\u0113mu kompens\u0101cijas meh\u0101nismu. T\u0101p\u0113c mums v\u0113l ir daudz dar\u0101m\u0101.\u201d<\/p>\n

Izaicin\u0101jumi, kas aizrauj<\/strong><\/h3>\n

Nestabilas pieg\u0101des \u0137\u0113des, jaunas \u0123en\u0113risk\u0101s z\u0101les un samazin\u0101ta jaunu z\u0101\u013cu izplat\u012bba tirg\u016b COVID d\u0113\u013c ir tikai da\u017ei no \u0161\u012b gada izaicin\u0101jumiem. Ar\u012b kar\u0161 Ukrain\u0101 ir ietekm\u0113jis pasaules tirgu.<\/p>\n

Ta\u010du katrs jauns izaicin\u0101jums iedvesmo. A. Gonak virz\u012bt\u0101jsp\u0113ks ir jauni projekti un m\u0113r\u0137i, un rado\u0161i probl\u0113mu risin\u0101jumu mekl\u0113jumi.<\/p>\n

\u201cNesen m\u016bsu uz\u0146\u0113mum\u0101 ierad\u0101s person\u0101la speci\u0101liste. Vi\u0146a bija p\u0101rsteigta, ka p\u0113c 14 uz\u0146\u0113mum\u0101 pavad\u012btiem gadiem joproj\u0101m esmu ideju un iedvesmas pilns. L\u016bk, t\u0101 tas ar\u012b notiek, ja darbojamies jom\u0101, kas pal\u012bdz gl\u0101bt dz\u012bv\u012bbas,\u201d A. Gonak pasmaida un pietic\u012bgi parausta plecus\u2026<\/p>\n","protected":false},"excerpt":{"rendered":"

Anton Gonak uz\u0146\u0113mum\u0101 \u201cNorameda\u201d s\u0101ka str\u0101d\u0101t pirms 14 gadiem. Jaunais speci\u0101lists toreiz to d\u0113v\u0113ja par “viena aktiera te\u0101tri”. \u0160obr\u012bd tie ir vair\u0101ki komp\u0101nijas \u201cNorameda\u201d cilv\u0113ki, kuri str\u0101d\u0101 onkolo\u0123ijas, hematolo\u0123ijas un transplantolo\u0123ijas nozar\u0113, un A.Gonak vada \u0161o noda\u013cu. “Jaunu produktu ievie\u0161ana tirg\u016b, p\u0101rdo\u0161ana un m\u0101rketings ir m\u016bsu ikdiena, ar\u012b darbs pie da\u017e\u0101diem projektiem,” st\u0101sta A. Gonak. […]<\/p>\n","protected":false},"author":220,"featured_media":7610,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_links_to":"","_links_to_target":""},"categories":[141],"tags":[],"_links":{"self":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/7623"}],"collection":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/users\/220"}],"replies":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/comments?post=7623"}],"version-history":[{"count":1,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/7623\/revisions"}],"predecessor-version":[{"id":7624,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/7623\/revisions\/7624"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media\/7610"}],"wp:attachment":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media?parent=7623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/categories?post=7623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/tags?post=7623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}